Mather Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-884
| Closed | -$198K | – | 1730 |
|
|
2025
Q1 | $198K | Sell |
884
-225
| -20% | -$50.4K | ﹤0.01% | 590 |
|
|
2024
Q4 | $363K | Sell |
1,109
-357
| -24% | -$117K | ﹤0.01% | 425 |
|
|
2024
Q3 | $440K | Buy |
1,466
+143
| +11% | +$42.9K | 0.01% | 394 |
|
|
2024
Q2 | $524K | Buy |
1,323
+142
| +12% | +$56.2K | 0.01% | 406 |
|
|
2024
Q1 | $416K | Hold |
1,181
| – | – | 0.01% | 377 |
|
|
2023
Q4 | $416K | Sell |
1,181
-54
| -4% | -$19K | 0.01% | 388 |
|
|
2023
Q3 | $463K | Buy |
1,235
+46
| +4% | +$17.3K | 0.01% | 338 |
|
|
2023
Q2 | $455K | Buy |
1,189
+297
| +33% | +$114K | 0.01% | 366 |
|
|
2023
Q1 | $309K | Buy |
+892
| New | +$309K | 0.01% | 389 |
|
|
2022
Q4 | – | Sell |
-1,011
| Closed | -$249K | – | 513 |
|
|
2022
Q3 | $249K | Sell |
1,011
-12
| -1% | -$2.96K | 0.01% | 410 |
|
|
2022
Q2 | $309K | Buy |
+1,023
| New | +$309K | 0.01% | 303 |
|